| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.3 |